Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Mainz Biomed (MYNZ) Equity Ratio (2020 - 2025)

Mainz Biomed's Equity Ratio history spans 5 years, with the latest figure at 0.46 for Q4 2024.

  • For Q4 2024, Equity Ratio rose 116.61% year-over-year to 0.46; the TTM value through Dec 2024 reached 0.46, up 116.61%, while the annual FY2024 figure was 0.46, 116.61% up from the prior year.
  • Equity Ratio for Q4 2024 was 0.46 at Mainz Biomed, up from 0.21 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.7 in Q4 2022 and bottomed at 4.07 in Q4 2020.
  • The 5-year median for Equity Ratio is 0.46 (2024), against an average of 0.41.
  • The largest annual shift saw Equity Ratio crashed 69.72% in 2023 before it skyrocketed 116.61% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 4.07 in 2020, then soared by 115.56% to 0.63 in 2021, then increased by 9.93% to 0.7 in 2022, then plummeted by 69.72% to 0.21 in 2023, then surged by 116.61% to 0.46 in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Equity Ratio are 0.46 (Q4 2024), 0.21 (Q4 2023), and 0.7 (Q4 2022).